Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aniket Patel

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
4-(2-pyridyl)piperazine-1-carboxamides: potent vanilloid receptor 1 antagonistsQun Sun, Laykea Tafesse, Khondaker Islam, et al.
Ultramicroscopy|February 13, 2023
A reference-area-free strain mapping method using precession electron diffraction dataDexin Zhao, Aniket Patel, Aaron Barbosa, et al.
Journal of Medicinal Chemistry|July 25, 2014
Structure-activity relationship studies and discovery of a potent transient receptor potential vanilloid (TRPV1) antagonist 4-[3-chloro-5-[(1S)-1,2-dihydroxyethyl]-2-pyridyl]-N-[5-(trifluoromethyl)-2-pyridyl]-3,6-dihydro-2H-pyridine-1-carboxamide (V116517) as a clinical candidate for pain managementLaykea Tafesse, Toshiyuki Kanemasa, Noriyuki Kurose, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
4-(2-pyridyl)piperazine-1-carboxamides: potent vanilloid receptor 1 antagonistsQun Sun, Laykea Tafesse, Khondaker Islam, et al.
Ultramicroscopy|February 13, 2023
A reference-area-free strain mapping method using precession electron diffraction dataDexin Zhao, Aniket Patel, Aaron Barbosa, et al.
Journal of Medicinal Chemistry|July 25, 2014
Structure-activity relationship studies and discovery of a potent transient receptor potential vanilloid (TRPV1) antagonist 4-[3-chloro-5-[(1S)-1,2-dihydroxyethyl]-2-pyridyl]-N-[5-(trifluoromethyl)-2-pyridyl]-3,6-dihydro-2H-pyridine-1-carboxamide (V116517) as a clinical candidate for pain managementLaykea Tafesse, Toshiyuki Kanemasa, Noriyuki Kurose, et al.
Pageof 2